Tower Research Capital (TRC)’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$542K Buy
31,888
+16,935
+113% +$288K 0.01% 914
2025
Q1
$292K Buy
14,953
+13,581
+990% +$265K 0.01% 1158
2024
Q4
$34K Sell
1,372
-5,172
-79% -$128K ﹤0.01% 2813
2024
Q3
$160K Sell
6,544
-21,819
-77% -$535K ﹤0.01% 1825
2024
Q2
$665K Buy
28,363
+22,319
+369% +$523K 0.01% 1086
2024
Q1
$200K Sell
6,044
-218
-3% -$7.2K ﹤0.01% 1413
2023
Q4
$170K Buy
6,262
+2,168
+53% +$59K ﹤0.01% 2231
2023
Q3
$98.5K Sell
4,094
-7,325
-64% -$176K ﹤0.01% 1990
2023
Q2
$365K Buy
11,419
+5,759
+102% +$184K 0.01% 1167
2023
Q1
$173K Buy
5,660
+4,090
+261% +$125K 0.01% 1448
2022
Q4
$61K Sell
1,570
-32,893
-95% -$1.28M ﹤0.01% 2188
2022
Q3
$1.64M Buy
34,463
+10,281
+43% +$490K 0.03% 495
2022
Q2
$936K Buy
24,182
+1,433
+6% +$55.5K 0.02% 735
2022
Q1
$1.3M Buy
22,749
+20,059
+746% +$1.15M 0.01% 701
2021
Q4
$215K Sell
2,690
-1,626
-38% -$130K ﹤0.01% 1708
2021
Q3
$376K Buy
4,316
+2,121
+97% +$185K 0.01% 1195
2021
Q2
$283K Sell
2,195
-19,370
-90% -$2.5M 0.01% 1642
2021
Q1
$1.73M Buy
21,565
+18,075
+518% +$1.45M 0.03% 535
2020
Q4
$285K Sell
3,490
-14,349
-80% -$1.17M 0.01% 1431
2020
Q3
$439K Buy
17,839
+15,225
+582% +$375K ﹤0.01% 1824
2020
Q2
$73K Buy
+2,614
New +$73K ﹤0.01% 2739